Coronavirus COVID-19: WHO expects anti-malarial drug hydroxychloroquine safety findings by mid-June
The World Health Organization (WHO) on Tuesday (May 26) said that it will conduct a swift review of data on anti-malarial drug hydroxychloroquine by mid-June after the global health body suspended the use of HCQ in a trial on the treatment of coronavirus COVID-19 patients due to safety concerns.
May 27, 2020, 06:33 AM IST
Times likes these bring friends closer, says PM Modi after US President Donald Trump thanks India for HCQ export
Hours after US President Donald Trump thanked India for clearing export of hydroxychloroquine (HCQ), the anti-malaria drug dubbed as a game-changer in the fight against coronavirus COVID-19 pandemic by some experts, Prime Minister Narendra Modi replied to Trump saying times likes these bring friends closer.
Apr 09, 2020, 10:41 AM IST
